Forian Inc.: Bylaws amended and restated in their entirety (effective 2026-05-15).
“on May 15, 2026, the Company’s articles of incorporation and bylaws were each amended and restated in their entirety”
Forian Inc. — fact timeline
Source-grounded facts extracted from Forian Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Forian Inc.: Articles of incorporation amended and restated in their entirety (effective 2026-05-15).
“on May 15, 2026, the Company’s articles of incorporation and bylaws were each amended and restated in their entirety”
Forian Inc. underwent a change of control involving 2025 Acquisition Company, LLC for $2.17 per share in cash (closed 2026-05-15).
“the “ Offer ”) to acquire any and all of the issued and outstanding shares of common stock, par value $0.0001 per share of the Company (the “ Shares ”), at a purchase price of $2.17 per Share, in cash, without interest thereon and less any applicable tax withholding (the “ Offer Price ”). The Offer and related withdrawal rights expired as scheduled one”
Kristiina Vuori, M.D., Ph.D. resigned as director at Forian Inc..
“At the Effective Time, Mark J. Adler, M.D., Ian G. Banwell, Adam Dublin, Jennifer Hajj, Shahir Kassam-Adams, Alyssa Varadhan and Kristiina Vuori, M.D., Ph.D. each resigned from the board of directors of the Company (the “ Board ”) and from all committees of the Board on which they served, and Max Wygod remained as the sole director of the Surviving Corporation.”
Alyssa Varadhan resigned as director at Forian Inc..
“At the Effective Time, Mark J. Adler, M.D., Ian G. Banwell, Adam Dublin, Jennifer Hajj, Shahir Kassam-Adams, Alyssa Varadhan and Kristiina Vuori, M.D., Ph.D. each resigned from the board of directors of the Company (the “ Board ”) and from all committees of the Board on which they served, and Max Wygod remained as the sole director of the Surviving Corporation.”
Shahir Kassam-Adams resigned as director at Forian Inc..
“At the Effective Time, Mark J. Adler, M.D., Ian G. Banwell, Adam Dublin, Jennifer Hajj, Shahir Kassam-Adams, Alyssa Varadhan and Kristiina Vuori, M.D., Ph.D. each resigned from the board of directors of the Company (the “ Board ”) and from all committees of the Board on which they served, and Max Wygod remained as the sole director of the Surviving Corporation.”
Jennifer Hajj resigned as director at Forian Inc..
“At the Effective Time, Mark J. Adler, M.D., Ian G. Banwell, Adam Dublin, Jennifer Hajj, Shahir Kassam-Adams, Alyssa Varadhan and Kristiina Vuori, M.D., Ph.D. each resigned from the board of directors of the Company (the “ Board ”) and from all committees of the Board on which they served, and Max Wygod remained as the sole director of the Surviving Corporation.”
Adam Dublin resigned as director at Forian Inc..
“At the Effective Time, Mark J. Adler, M.D., Ian G. Banwell, Adam Dublin, Jennifer Hajj, Shahir Kassam-Adams, Alyssa Varadhan and Kristiina Vuori, M.D., Ph.D. each resigned from the board of directors of the Company (the “ Board ”) and from all committees of the Board on which they served, and Max Wygod remained as the sole director of the Surviving Corporation.”
Ian G. Banwell resigned as director at Forian Inc..
“At the Effective Time, Mark J. Adler, M.D., Ian G. Banwell, Adam Dublin, Jennifer Hajj, Shahir Kassam-Adams, Alyssa Varadhan and Kristiina Vuori, M.D., Ph.D. each resigned from the board of directors of the Company (the “ Board ”) and from all committees of the Board on which they served, and Max Wygod remained as the sole director of the Surviving Corporation.”
Mark J. Adler, M.D. resigned as director at Forian Inc..
“At the Effective Time, Mark J. Adler, M.D., Ian G. Banwell, Adam Dublin, Jennifer Hajj, Shahir Kassam-Adams, Alyssa Varadhan and Kristiina Vuori, M.D., Ph.D. each resigned from the board of directors of the Company (the “ Board ”) and from all committees of the Board on which they served, and Max Wygod remained as the sole director of the Surviving Corporation.”
Forian Inc. entered into Agreement and Plan of Merger with 2025 Acquisition Company, LLC and Bravo Merger Sub, Inc. (effective 2026-04-02).
“On April 2, 2026, Forian Inc., a Maryland corporation (the " Company " or " Forian "), entered into an Agreement and Plan of Merger (the " Merger Agreement "), by and among the Company, 2025 Acquisition Company, LLC, a Delaware limited liability company (" Parent "), and Bravo Merger Sub, Inc., a Maryland corporation and wholly owned subsidiary of Parent (" Purchaser ").”
Forian Inc. reported financial results for quarter and year ended December 31, 2025.
“On March 27, 2026, the Company issued a press release announcing its financial results for the quarter and full year ended December 31, 2025.”
Forian Inc.: Company redomiciled from Delaware to Maryland via statutory conversion, with new charter and bylaws (effective 2026-01-09).
“The Redomiciliation was effective at 12:01 a.m. Eastern Time on January 9, 2026”
Forian Inc. engaged BDO USA, P.C. as its auditor.
“On June 26, 2025, Audit Committee approved the engagement of BDO USA, P.C. ("BDO") as the Company's independent registered public accounting firm.”
Forian Inc. dismissed CBIZ CPAs P.C. as its auditor.
“On June 26, 2025, the Audit Committee of the Board of Directors of Forian, Inc. (the "Company") dismissed CBIZ CPAs P.C. ("CBIZ") as the Company's independent registered accounting firm.”
Edward Spaniel, Jr. resigned as Executive Vice President, General Counsel and Corporate Secretary at Forian Inc..
“On April 28, 2025, Edward Spaniel, Jr., Executive Vice President, General Counsel and Corporate Secretary of Forian Inc. (the “Company”), notified the Company of his resignation from all of his positions with the Company and its subsidiaries and affiliates, effective May 23, 2025.”
Forian Inc. reported the quarter ended March 31, 2024 results: revenue $4,877,378, net income $(1,212,615), EPS $(0.04).
“Results ● Forian delivered the following results for the first quarter of 2024: Three Months Ended March 31, Period- over- Period % Change 2024 Unaudited 2023 Unaudited Revenue $ 4,877,378 $ 4,870,387 0% Loss from continuing operations, net of tax $ (1,212,615 ) $ (2,248,799 ) 46% Income from discontinued operations, net of tax $ - $ 8,747,278 100% Net (loss) income”
Forian Inc. updated its Year ending December 31, 2024 guidance (initiated).
“Full Year 2024 Outlook Based on information as of March 28, 2024, the Company is sharing the following outlook for the year ending December 31, 2024: ● Revenue growth is expected to be in the range of 5% to 15% ● Adjusted EBITDA 1 margin is expected to be in the range of 8% to 12%”
Forian Inc. reported Twelve Months Ended December 31, 2023 results: revenue $20,481,330, net income $11,106,687, EPS $0.34.
“Full Year 2023 Financial Results Forian delivered the following results for the full year 2023: Twelve Months Ended December 31, 2023 Unaudited 2022 Unaudited Period-over- Period % Change Revenue $ 20,481,330 $ 16,418,141 25% Income (loss) from continuing operations, net of tax $ 1,733,430 $ (19,191,990 ) 109% Income (loss) from discontinued operations, net of tax $ 9,373,257 $ (6,779,981 ) 238% Net Income (loss) $ 11,106,687 $ (25,971,971 ) 143% Income (loss) from continuing operations, net of tax per share - diluted $ 0.05 $ (0.60 ) 108% Income (loss) from discontinued operations, net of tax per share - diluted $ 0.29 $ (0.21 ) 238% Income (loss) per share - diluted $ 0.34 $ (0.81 ) 142% Adjusted EBITDA (a non-GAAP financial measure defined below) $ 2,336,380 $ (6,707,809 ) 135%”
Forian Inc. reported Three Months Ended December 31, 2023 results: revenue $5,368,932, net income $1,388,943, EPS $0.04.
“Fourth Quarter 2023 Financial Results Forian delivered the following results for the fourth quarter of 2023: Three Months Ended December 31, 2023 Unaudited 2022 Unaudited Period-over- Period % Change Revenue $ 5,368,932 $ 4,969,673 8% Loss from continuing operations, net of tax $ (381,014 ) $ (1,900,105 ) 80% Income (loss) from discontinued operations, net of tax $ 1,769,957 $ (1,656,609 ) 207% Net Income (loss) $ 1,388,943 $ (3,556,714 ) 139% Loss from continuing operations, net of tax per share - diluted $ (0.01 ) $ (0.06 ) 83% Income (loss) from discontinued operations, net of tax per share - diluted $ 0.05 $ (0.05 ) 200% Income (loss) per share - diluted $ 0.04 $ (0.11 ) 136% Adjusted EBITDA (a non-GAAP financial measure defined below) $ 1,033,648 $ (425,434 ) 343%”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.